Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Year-over-year book value per share growth
Latest
-44.44%
↓ 260% vs avg
Percentile
P18
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
27.82%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -44.44% |
| Q2 2025 | -20.57% |
| Q1 2025 | 372.45% |
| Q4 2024 | 54.40% |
| Q3 2024 | -40.91% |
| Q2 2024 | -19.04% |
| Q1 2024 | -25.40% |
| Q4 2023 | 1576.04% |
| Q3 2023 | -123.71% |
| Q2 2023 | -55.39% |
| Q1 2023 | -53.73% |
| Q4 2022 | -12.31% |
| Q3 2022 | -34.95% |
| Q2 2022 | -26.31% |
| Q1 2022 | -23.82% |
| Q4 2021 | -17.04% |
| Q3 2021 | -87.53% |
| Q2 2021 | 1246.09% |
| Q1 2021 | 105.20% |
| Q4 2020 | -1338.87% |
| Q3 2020 | -11.41% |
| Q2 2020 | -88.78% |
| Q1 2020 | -6.68% |
| Q4 2019 | 29.12% |
| Q3 2019 | -18.53% |
| Q2 2019 | -13.60% |
| Q1 2019 | -12.90% |
| Q4 2018 | -71.05% |
| Q3 2018 | -10.55% |
| Q2 2018 | -12.58% |
| Q1 2018 | -10.83% |
| Q4 2017 | -11.05% |
| Q3 2017 | -11.07% |
| Q2 2017 | -14.34% |
| Q1 2017 | -12.47% |
| Q4 2016 | -16.68% |
| Q3 2016 | -25.37% |
| Q2 2016 | 34.65% |
| Q1 2016 | -22.07% |
| Q4 2015 | -11.04% |